Unknown

Dataset Information

0

Lyn regulates creatine uptake in an imatinib-resistant CML cell line.


ABSTRACT:

Background

Imatinib mesylate (imatinib) is the first-line treatment for newly diagnosed chronic myeloid leukemia (CML) due to its remarkable hematologic and cytogenetic responses. We previously demonstrated that the imatinib-resistant CML cells (Myl-R) contained elevated Lyn activity and intracellular creatine pools compared to imatinib-sensitive Myl cells.

Methods

Stable isotope metabolic labeling, media creatine depletion, and Na+/K+-ATPase inhibitor experiments were performed to investigate the origin of creatine pools in Myl-R cells. Inhibition and shRNA knockdown were performed to investigate the specific role of Lyn in regulating the Na+/K+-ATPase and creatine uptake.

Results

Inhibition of the Na+/K+-ATPase pump (ouabain, digitoxin), depletion of extracellular creatine or inhibition of Lyn kinase (ponatinib, dasatinib), demonstrated that enhanced creatine accumulation in Myl-R cells was dependent on uptake from the growth media. Creatine uptake was independent of the Na+/creatine symporter (SLC6A8) expression or de novo synthesis. Western blot analyses showed that phosphorylation of the Na+/K+-ATPase on Tyr 10 (Y10), a known regulatory phosphorylation site, correlated with Lyn activity. Overexpression of Lyn in HEK293 cells increased Y10 phosphorylation (pY10) of the Na+/K+-ATPase, whereas Lyn inhibition or shRNA knockdown reduced Na+/K+-ATPase pY10 and decreased creatine accumulation in Myl-R cells. Consistent with enhanced uptake in Myl-R cells, cyclocreatine (Ccr), a cytotoxic creatine analog, caused significant loss of viability in Myl-R compared to Myl cells.

Conclusions

These data suggest that Lyn can affect creatine uptake through Lyn-dependent phosphorylation and regulation of the Na+/K+-ATPase pump activity.

General significance

These studies identify kinase regulation of the Na+/K+-ATPase as pivotal in regulating creatine uptake and energy metabolism in cells.

SUBMITTER: Okumu DO 

PROVIDER: S-EPMC7055176 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lyn regulates creatine uptake in an imatinib-resistant CML cell line.

Okumu Denis O DO   Aponte-Collazo Lucas J LJ   Dewar Brian J BJ   Cox Nathan J NJ   East Michael P MP   Tech Katherine K   McDonald Ian M IM   Tikunov Andrey P AP   Holmuhamedov Ekhson E   Macdonald Jeffrey M JM   Graves Lee M LM  

Biochimica et biophysica acta. General subjects 20191224 4


<h4>Background</h4>Imatinib mesylate (imatinib) is the first-line treatment for newly diagnosed chronic myeloid leukemia (CML) due to its remarkable hematologic and cytogenetic responses. We previously demonstrated that the imatinib-resistant CML cells (Myl-R) contained elevated Lyn activity and intracellular creatine pools compared to imatinib-sensitive Myl cells.<h4>Methods</h4>Stable isotope metabolic labeling, media creatine depletion, and Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitor experi  ...[more]

Similar Datasets

| S-EPMC5056971 | biostudies-literature
| S-EPMC6888972 | biostudies-literature
| S-EPMC4038039 | biostudies-literature
| S-EPMC4226676 | biostudies-literature
| S-EPMC6685516 | biostudies-literature
| S-EPMC8473700 | biostudies-literature
| S-EPMC8654699 | biostudies-literature
| S-EPMC3339412 | biostudies-literature
| S-EPMC4002272 | biostudies-literature
| S-EPMC4968618 | biostudies-literature